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Abstract
This reviews the first of a tripartite symposia series dealing with novel neuroscientific technologies,
the nature of consciousness and being, and the questions that arise from such interactions. The
event took place on May 8 2009, at Georgetown University, and brought together ten leading
figures on fields ranging from Neuroscience and Robotics to Philosophy, that commented on their
research and provided ethical, moral and practical insight and perspectives into how these
technologies can shape the future of neuroscientific and human development, as well as denoting
the potential abuses and the best way to proceed about them.
Introduction
On May 8, 2009, The Nour Foundation, a public charita-
ble organization and NGO in special consultative status to
the United Nations, together with Georgetown University,
Blackfriars Hall at Oxford University, and the Potomac
Institute for Policy Studies' Center for Neurotechnology
Studies, presented The Paradox of Neurotechnology, a
thought-provoking symposium exploring the technolo-
gies of neuroscience and the ways in which these tools and
methods can lead to a deeper understanding of the nature
of being. The discussions brought together leaders in the
field to address the pressing issues, questions, and poten-
tial dilemmas arising in and from the use of neurotech-
nologies, and how such progress prompts deeper
neuroethical considerations. The symposium was the first
in a three-part series, with subsequent meetings to be held
at the University of Oxford on 22 July 2009, and the
United Nations in New York on 11 September 2009. Fur-
ther information regarding the symposium can be found
on their website [1].
The symposium began with an introduction and keynote
by Prof. James Giordano, Professor of Neuroscience, Eth-
ics, and Philosophy at the Institute for Psychological Sci-
ences, Centre for Philosophical Psychology; Fellow,
Blackfriars Hall, University of Oxford; Director of the
Center for Neurotechnology Studies and Chair of Aca-
demic Programs at the Potomac Institute for Policy Stud-
ies in Virginia; and former Samueli-Rockefeller Professor
of Medicine and Neuroscience and Director of the Pro-
gram for Brain, Mind and Healing Research at the George-
town University Medical Center, where he maintains an
adjunct professorship. Giordano set the tone by positing
that as we approach the frontier realms of science, we
encounter new and novel possibilities that require us to
deal with the contingencies arising not only from what is
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yet unknown, but what may ultimately remain unknowa-
ble. He outlined the basic premises of a philosophy of sci-
ence to address and unify domains of metaphysics,
epistemology, anthropology and ethics, and proposed a
paradigm for precautionary progress that involves a prag-
matically balanced optimism grounded in proactive
responsibility.
Following Prof. Giordano, Dr. Erik Parens, Senior
Research Scholar at the Hastings Center and Visiting Pro-
fessor at Sarah Lawrence College, focused on the ways in
which technologies such as fMRI form our self-images to
address the benefits and dangers scientists encounter
when relying on the use of novel and emerging tech-
niques. Parens spoke to the issues surrounding definitions
of normality, and how these constructs can affect the way
in which we treat those who fall outside of the artificial,
and sometimes arbitrary, distinctions and boundaries
drawn while describing what is acceptable or desirable.
Dr. Dennis McBride, President Emeritus of the Potomac
Institute for Policy Studies and adjunct professor at Geor-
getown University, raised the question of whether con-
temporary psychology as a discipline is capable of
accommodating the conditions required for reconciling
brain science with studies of the mind. McBride's thesis
calls for an integrative neuroethology that allows for both
objective assessment and the possibility for correlation of
more subjective aspects of cognition (such as emotion,
motivation, intentionality) to biological and environ-
mental variables.
Dr. Layne Kalbfleisch, Assistant Professor in Educational
Psychology at the College of Education and Human
Development at George Mason University and Pomata
Term Professor of Cognitive Neuroscience at George
Mason's Krasnow Institute for Advanced Study, provided
an overview of the ways in which neurotechnologies such
as fMRI and other forms of neuroimaging have become
increasingly representative of "real world" cognition.
Kalbfleisch elucidated what she has called "neuro-myths"
that reflect misconceptions held on the part of both the
public and some members of the academic community
about the capacities and limitations of neurotechnolo-
gies, and, by extension, the brain-mind. Illustrating the
recent surge in mass market books addressing the brain,
mind and cognitive capacity, she advocated a more
explicit and direct communication of how abilities and
constraints of neurotechnology allow and/or restrict
insight to, and predictions about, the potential of the
brain-mind, and those fields that employ this knowledge
in research and everyday applications.
In a compelling lecture, Dr. Kevin FitzGerald, Associate
Professor of Molecular Genetics and David Lauler Chair of
Catholic Healthcare Ethics at Georgetown University,
dealt with the notion of "personalized medicine" as
applied to neurogenetics, and raised questions of how to
balance the progressive ubiquity of individual patients'
information in an increasingly accessible medical data
system with libertarian concerns and the need for privacy.
As well, FitzGerald addressed the question of "what we
really know and don't know" about the capacities and
limits to categorize and/or change the self, as based upon
neurogenetic data. In this light, he discussed the process
of patients' informed consent and the ethical dilemmas
that could occur as we respond to escalating socio-eco-
nomic pressures to "use what we've got" in practical appli-
cations. Here again, the treatment-enhancement/
normality debate was brought to the fore, and the core
theme of linking epistemology to an applied ethic of
research and clinical care was highlighted.
Dr. Jeffrey Krichmar, Assistant Professor in the Depart-
ment of Cognitive Sciences at the University of California,
Irvine, shared his cutting-edge work on robotics and neu-
ral networks. Krichmar highlighted work on artificially
created machines that approach decisional-processes
which may ultimately obtain the parameters of human
capacity, emphasizing that we should consider these
potentialities beyond the mere utility of robots, for it may
be that as a consequence of such advanced and iterative
synthetic neural network development robots (and per-
haps other computational devices) will be able to mani-
fest some form of consciousness. At first impression, this
would allow a deeper insight to the mechanisms of con-
sciousness, albeit not necessarily the same substrates as
those of human or animal consciousness per se, but upon
further reflection also instantiates moral consideration of
what these "conscious" devices may feel, and how such
sentience might dictate how we treat machines.
Dr. Susan Schneider, Assistant Professor in the Depart-
ment of Philosophy at the University of Pennsylvania and
an affiliated faculty member at the Center for Cognitive
Neuroscience and the Institute for Research in Cognitive
Science, approached the topic of neurotechnology and its
implications and effects on humanity from a considerably
deeper metaphysical standpoint. Working to afford
insights to the trans-human potential of any neurotech-
nology, Schneider addressed how ontological values may
need to be readdressed and perhaps reconsidered as we
move toward increasingly integrative use and employ-
ment of neurotechnological devices on a variety of levels,
from the most sublime to the extreme. Moreover, Schnei-
der's thesis – that pervasiveness and progression of the
technologic trend mandates not only philosophical reflec-
tion, but evaluation of the ways this will define the
human person and human condition in practical terms –
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ogy in both the larger treatment-enhancement debate and
the entire trans-humanist movement, both of which con-
stitute contentious, provocative, and important aspects of
the discourse.
Also presenting from the University of Pennsylvania was
Dr. Sheri Alpert, Lecturer and Associate Fellow at the
Center for Bioethics, who discussed the ethical conun-
drums that arise with novel medical technologies, specifi-
cally those that affect the brain-mind and the subjective
dimensions of emotion, consciousness and intention. Of
particular focus was the development and use of new neu-
ropsychopharmacological agents in light of extant ambi-
guities related to: 1) the actual definition of normality as
relates to brain-mind function and its manifestations in
various social contexts; 2) the mechanisms of action and
the effect of these agents, as based upon a contingent
understanding of neural function, and 3) the treatment-
enhancement question, writ both small (viz., in individu-
als) and large (viz., as a social construct and practical
"kind," reflective of a somewhat Szaszian perspective). To
illustrate, Dr. Alpert constructed a hypothetical case sce-
nario that addressed the actions and effects of a fictional
psychopharmacologic agent, and how social values sys-
tems are exploited to justify use and misuse. Her lecture
highlighted the ways in which social and market forces
can influence scientific funding, development and appli-
cation(s), and how this is an important factor to sustain
the obligation to consider and solicit bioethical insight
and analyses at all stages of neurotechnology research and
development.
In a most thought-provoking, if not provocative, lecture
Dr. Sam Parnia, Clinical Research Fellow at the Weill Cor-
nell Medical School in New York and Founder and Direc-
tor of the Human Consciousness Project at the University
of Southampton in the UK – a multidisciplinary collabo-
ration of international scientists and physicians who have
joined forces to research the nature of consciousness and
its relationship with the brain – described his studies
examining conscious processes during cardiac arrest.
Without doubt, these studies present numerous chal-
lenges and potentially open new vistas from a neuroscien-
tific perspective. Although affording insight to the
mechanistic events and phenomenal experiences of con-
sciousness during the dying process, such insights raise
other, more ontological (if not cosmological) questions
about the nature of consciousness, self, and the process of
life and death as they relate to a philosophy and perhaps
physics of the natural universe, prompting a variety of eth-
ical questions and potential dilemmas.
Finally, renowned philosopher Prof. Roger Scruton of the
Institute for the Psychological Sciences in Virginia and the
Centre for Philosophical Psychology at Blackfriars Hall,
Oxford University, presented a compelling lecture in
which he addressed and considered the ways in which our
cultural and political beliefs affect the scope and conduct
of neuroscientific research and its applications in society.
Scruton argued that while the neuroscientific approach is
necessary, it is not, nor should it be, sufficient for a "com-
plete" assessment and regard for the human person, and/
or other organisms. Scruton warned against the overuse
and misuse of neuroscientific information, cautioned
against mereological thinking, and urged awareness of the
misconception that any and all new data constitute
"knowledge." In suggesting that we prescind, Scruton
called for an acknowledgment of the "limits of both tech-
nology and knowledge," and invoked a collective intellec-
tual honesty that accepts what is known and what is yet to
be discovered.
Overall, the symposium presented the issue of neurotech-
nology holistically in a form that allowed for open
thought and dialogue and a broadening view of science,
scientists, and technology – not in isolation, but as con-
stituents of social culture(s) – and the direction in which
neurotechnological progress might and perhaps should
progress in the future. Rather than being over-indulged
with a single perspective as the truth, the symposium rein-
forced the tangential nature of much of what we know
about brains, minds, and consciousness, though given the
inertia of neurotechnology we now have an ever-widening
opportunity to explore many, and perhaps partial, truths.
As summarized by Dr. Giordano in his concluding
remarks: "We must recognize that, as foretold by Lenk and
Jonas, the status quo is  progress. This pendulum of
progress cannot be impeded, nor will it be reversed. And
perhaps it should not be. The goal, therefore, is to recog-
nize our responsibility to engage the profound ethical,
social and legal implications of the truths we may seek
and reveal about the brain and mind through our use of
technology, and acknowledge its potential uses as well as
misuses in both neuroscience and society. To do so will
require that we identify the gaps in knowledge and safety,
analyze how such gaps can incur burdens, threats and
risks, and work to ensure that precaution is taken so as not
to be exclusory of technology, but to advance with
humanitarian concern and prudence," which speaks to
the focus of the symposium series on the whole.
The next meeting, "Brain, Mind & the Nature of Being," to
be held at the Ioannou Centre for Classical Studies,
Oxford, England on 22 July specifically addresses those
ways in which neuroscience and neurotechnology have,
have not, and perhaps cannot reveal aspects of the human
condition such as aesthetics, social dynamics, and spiritu-
ality, and how the construct of transcendence may be
intrinsic to any consideration of the brain-mind, at least
as we currently know it. This symposium will be followedPublish with BioMed Central    and   every 
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by a conference on September 11 at the United Nations,
"Toward a Common Morality" that will address the neural
basis of moral sense and decision making, and how such
processes may illustrate a common basis for moral con-
sideration and human "good."
Ultimately, as Dr. Joseph Salim, Vice-President of the
Nour Foundation, aptly stated: "As technological
advances in neuroscience continue to demonstrate that
human beings share a common physical and neurological
constitution, it increasingly behooves us to explore the
scientific underpinnings of seemingly universal emo-
tional and psychological behaviors if we are to work
toward developing a more holistic and integrated under-
standing of the human condition."
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